Teresa Jones, M.D.

Program Director: Division of Diabetes, Endocrinology, & Metabolic Diseases

Diabetic Foot Consortium, diabetic wound healing, diabetic neuropathy, basic and clinical research of diabetes complications involving multiple organ systems

Responsibilities & Activities

I am the program director for the Diabetes Complications program that includes basic, translational and clinical research on diabetic neuropathy, diabetic wound healing, and diabetic ketoacidosis.

The program also includes basic research on the mechanisms of tissue damage from hyperglycemia and the other metabolic changes of diabetes and clinical research with outcome measures for multiple diabetic complications. I am the project scientist for the Diabetic Foot Consortium that will develop biomarkers for diabetic foot ulcers; the program officer for the Preventing Early Renal Loss in Type 1 Diabetes (PERL) trial; the NIDDK project scientist for the Trial to Assess Chelation Therapy 2 (TACT2) trial; and the program director for SBIR/STTR research on diabetes complications in the division of DEM.

Research Programs

Bioengineering, Biotechnology, & Imaging as applied to Diabetes, Metabolic, & Endocrine Diseases
Cutting-edge technologies and integrated approaches that treat and elucidate the underlying mechanisms of endocrine and metabolic diseases, including diabetes.

Diabetes: Treatment, Prevention, & Complications

Committees & Working Groups

Trans-NIH Medical Rehabilitation Coordinating Committee, NIDDK Representative
Metabolic Disorders Steering Committee of the Biomarkers Consortium of the Foundation for NIH, Member

Select Experience

Investigator, Intramural Research Program, NIDDK, NIH, 1995-2003

Fellowship - Board Certified in Endocrinology and Metabolism, NIH, 1987-1989

Residency - Board Certified in Internal Medicine, University of Minnesota, 1983-1986

M.D., Northwestern University Honors Program in Medical Education, 1983